All > Metastatic Renal Cell Carcinoma > Renal Cell Carcinoma

Combined Aerobic and Resistance Exercise Training for Kidney Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Kidney CancerCombined Aerobic and Resistance Exercise Training - Other
Eligibility
18 - 99
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing the effects of personalized exercises on quality of life and inflammation.

Eligible Conditions
  • Kidney Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Olaparib
1
Combined Aerobic and Resistance Exercise via videoconferencing
1
Resistance training

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: 2 years

2 years
Number of participants who adhere to the exercise intervention
Percentage of patients screened compared to patients enrolled
Percentage of patients who remained in the study and didn't drop off the study after enrollment
The incidence of grade 3-5 toxicities as per CTCAE 5.0
Week 24
Change in HRQoL as measured by FACT-G Questionnaire

Trial Safety

Safety Progress

1 of 3

Similar Trials

2
Olaparib
2
Combined Aerobic and Resistance Exercise via videoconferencing
1
Resistance training

Trial Design

1 Treatment Group

Supportive Care
1 of 1

Experimental Treatment

16 Total Participants · 1 Treatment Group

Primary Treatment: Combined Aerobic and Resistance Exercise Training · No Placebo Group · N/A

Supportive Care
Other
Experimental Group · 1 Intervention: Combined Aerobic and Resistance Exercise Training · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Who is running the clinical trial?

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLead Sponsor
536 Previous Clinical Trials
31,278 Total Patients Enrolled
Yasser Ged, MDPrincipal InvestigatorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Eligibility Criteria

Age 18 - 99 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have metastatic disease, as defined by RECIST 1.1.
You are about to start treatment or have been on treatment for a maximum of 4 weeks prior to signing consent.
You have histologically confirmed renal cell carcinoma.
You are physically able to participate in the exercise program as determined by the treating medical oncologist and after review by Physical medicine and rehabilitation physicians at Johns Hopkins.
You have hemoglobin ≥ 9.0 g/dL.
You have a serum creatinine level of 1.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top